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Introduction
Glycogen phosphorylase (EC 2.4.1.1) inhibitors (GPIs) have been considered as possible means for therapeutic intervention in type 2 diabetes and some other diseased states (e. g. early cardiac and cardiovascular disease in non-diabetics, cardiac arrhythmias, ischemic injuries, tumour growth) as rationalized in the recent review literature. [1] [2] [3] [4] [5] Among several compound classes 4, 6 glucose derivatives are one of the most intensively investigated inhibitors. 5, 7 The quoted review articles 5, 7 provide the reader with a detailed description of the structure-activity relationships (SAR) of glucose analogue GPIs, therefore, only those features are summarized hereinafter which form the direct basis of our compound design. NAcyl--D-glucopyranosylamines 8 (Chart 1, I: e. g. for R = 2-naphthyl K i measured against rabbit muscle GPb (RMGPb) 9 was 10-13 M 
Results and Discussion
For the formation of the heterocyclic parts of the target compounds oxidative ring closure of (thio)semicarbazones (similar to that applied for the syntheses of IB 15 ) was envisaged as the key step. To this end, the protected C-(-D-glucopyranosyl)formaldehyde semicarbazone 2 was prepared by a reaction of NH 2 C(=O)NHNH 2 with O-perbenzoylated -D-glucopyranosyl cyanide 17 1 in the presence of Raney Ni and NaH 2 PO 2 at 40 C (Scheme 1) as described earlier. 18 
O-Perbenzoylated 4-phenyl-[C-(-D-glucopyranosyl)formaldehyde]semicarbazone 3
5 was obtained in a similar way using PhNHC(=O)NHNH 2 as the trapping agent.
Debenzoylation was performed by the Zemplén protocol to result in moderate yields of semicarbazones 6 and 7.
In order to get thiosemicarbazones 4 and 5, acid catalyzed transimination of 2 was carried out because the direct transformation of -D-glucopyranosyl cyanide 1 into thiosemicarbazones failed. Thus, semicarbazone 2 was reacted with NH 2 C(=S)NHNH 2 or PhNHC(=S)NHNH 2 in glacial AcOH at 70 C to give the corresponding thiosemicarbazones 4 and 5, respectively.
Removal of the benzoyl protecting groups in 4 and 5 was carried out by LiOH in MeOH to
give compounds 8 and 9, respectively, in satisfactory yields. This observation is in accord with literature experiences. 19 Ring closing reactions of the precursors under oxidative conditions were studied next.
Semicarbazone 3 was reacted with Pb(OAc) 4 in glacial AcOH at 70 C to furnish O- The deprotected compounds were tested for their inhibition potency against rabbit muscle glycogen phosphorylase b (RMGPb) according to the protocol described earlier. 20 The results are summarized in Table 1 Interestingly, semicarbazones 6 and 7 (entry 6) and thiosemicarbazones 8 and 9 (entry 7), the "open chain" precursors of the target compounds of this work, showed week to moderate inhibition. Semicarbazones 6 and 7 are better inhibitors than the thiosemicarbazone counterparts 8 and 9. Phenyl derivatives 7 and 9 are more efficient than the unsubstituted compounds 6 and 8, respectively, and this is in agreement with the general trend to show stronger inhibition by those compounds which have a large(r) aromatic part in the aglycon. 4 A comparison of 7 (actually the best inhibitor in this study) to the biuret type inhibitor (entry 5)
indicates no significant difference in the inhibition constants. This may reveal that interactions of the whole NHCO linker moiety or its carbonyl group has probably less significance in binding to the enzyme than those of the "second" NHCO unit.
9 
Experimental

General methods
2-Phenylamino-5-(2,3,4,6-tetra-O-benzoyl--D-glucopyranosyl)-1,3,4-oxadiazole (10)
Semicarbazone 3 (0.20 g, 0.27 mmol) was dissolved in glacial AcOH (3 mL). Then Pb(OAc) 4 (0.18 g, 0.40 mmol) was added, and the mixture was stirred and heated at 70 °C. The reaction was monitored by TLC (1:2 EtOAc-hexane). When the reaction was complete, the reaction mixture was diluted with H 2 O (15 mL), and extracted with EtOAc (3 x 6ml). The organic phase was dried (MgSO 4 ), and evaporated under reduced pressure. The crude product was 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Hz, J 4,5 = 9.6 Hz, H-5). equiv.) was added, and the mixture was stirred at room temperature. The reaction was monitored by TLC (1:1 EtOAc-hexane). When the reaction was complete, the solvent was evaporated and the residue was purified by column chromatography. 
General procedure I for the synthesis of O-perbenzoylated 4-acyl-[C-(-Dglucopyranosyl)formaldehyde]semicarbazones
C-(2,3,4,6-Tetra-O-benzoyl--D-glucopyranosyl)formaldehyde
2-(4-tert-Butylbenzamido)-4-(4-tert-butylbenzoyl)-5-(2,3,4,6-tetra-O-benzoyl--Dglucopyranosyl)-Δ 2 -1,3,4-thiadiazoline (19)
2-Acetamido-5-(2,3,4,6-tetra-O-benzoyl--D-glucopyranosyl)-1,3,4-oxadiazole (20)
2-Benzamido
Preparation for the test compounds
General procedure IV for the Zemplén debenzoylation
An O-perbenzoylated compound (100 mg) was dissolved in dry MeOH (1 mL) and a solution of NaOMe (1 M in MeOH) was added to the solution in a catalytic amount. The reaction mixture was kept at rt. When the reaction was complete (TLC, 7:3 CHCl 3 -MeOH) the solution was neutralized with a cation exchange resin Amberlyst 15 (H + form). The resin was filtered off with suction, the filtrate was evaporated under reduced pressure. The crude product was purified by column chromatography.
General procedure V for the removal of O-benzoyl protecting groups
An O-perbenzoylated compound (100 mg) was dissolved in dry MeOH (14 mL) and LiOH (16 equiv.) was added. The reaction mixture was stirred at 0 °C. When the reaction was complete (TLC, 7:3 CHCl 3 -MeOH) the solution was neutralized with a cation exchange resin Amberlyst 15 (H + form). After filtration and removal of the solvent, the residue was purified by column chromatography. 
C-(-D-glucopyranosyl)formaldehyde semicarbazone (6)
From
4-Phenyl-[C-(-D-glucopyranosyl)formaldehyde]semicarbazone (7)
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